A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback